JAGSONPAL PHARMACEUTICALS LTD. Q1 FY26 Results
JAGSNPHARMQ1 FY26 ResultsAnnounced 26 Jul 2025, 12:38 pm| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 75.61 | 29.1% |
| Total Income | 78.44 | 27.9% |
| Expenditure | 64.01 | 22.1% |
| PBT | 14.43 | 65.7% |
| Net Profit | 10.79 | 64.0% |
| OPM | 18.80% | 4.28pp |
| NPM | 13.76% | 3.03pp |
| EPS | 1.60 | 63.3% |
Jagsonpal Pharmaceuticals Reports Q1 2025 Financial Results with 2,687.16 Million Revenue
26 Jul 2025 · 26 Jul 2025, 12:41 pm
Summary
Jagsonpal Pharmaceuticals has reported its financial results for Q1 2025. The company's revenue stands at 2,687.16 million. The results were approved in a Board Meeting that started at 11:55 A.M. and concluded at 12:30 P.M. The review report was issued by Walker Chandiok & Co LLP.
Key Highlights
- 1
Revenue for Q1 2025 is 2,687.16 million
- 2
Meeting of the Board of Directors held on 26th July 2025
- 3
Review report issued by Walker Chandiok & Co LLP
Informational and educational content only. Not investment advice.